Oorsprong van het eerstegraads netwerk van K. Jon Kowal
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
MediGene, Inc.
 MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met K. Jon Kowal via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| MEDIGENE AG | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Wisconsin | College/University | Doctorate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Corporate Officer/Principal | |
European Research Council
 European Research Council Investment Trusts/Mutual FundsMiscellaneous The European Research Council is an organization that provides grants for research projects. The organization is based in Brussels, Belgium. As a grantee, individuals are required to submit scientific and financial reports for assessment by ERC Scientific Officers. The organization emphasizes the importance of research ethics and compliance with legislation, disciplinary norms, and protection of research subjects. The responsibility for ethics lies with the individuals conducting the research, while the formal accountability lies with the signatory of the Grant Agreement, the Host Institution. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| Deutsche Forschungsgemeinschaft | College/University | Corporate Officer/Principal | |
| Institute of Molecular Immunology | Director/Board Member | ||
Medigene Immunotherapies GmbH
 Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Part of MediGene AG, Medigene Immunotherapies GmbH develops immunotherapy to treat cancer. The company is based in Planegg, Germany. The German company was founded in 2013 by Thomas Blankenstein, Dolores J. Schendel. The CEO is Axel-Sven Malkomes. Medigene Immunotherapies was acquired by MediGene AG on January 27, 2014 for $13.05 million. | Pharmaceuticals: Major | Chief Executive Officer | |
| German Cancer Aid | Corporate Officer/Principal |
Statistieken
Internationaal
| Duitsland | 7 |
| Verenigde Staten | 2 |
| België | 2 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
| Miscellaneous | 2 |
Operationeel
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Dolores Schendel | 9 |
- Beurs
- Insiders
- K. Jon Kowal
- Bedrijfsconnecties